semaglutide 1.25 mg Oral Wegovy approved for obesity management by FDA on December 23, 2025 Formulation: High‑dose oral (25 daily) — previously only available as weekly injections. Indication: Adults with obesity (BMI ≥30) related medical problems Ozempic 0.25MG 1 pen x

Adding or increasing resistance training, adjusting protein intake, or discussing a dose adjustment with your Rivas provider are more productive levers

Look for the FSA/HSA eligible label on applicable products

120 vegetarian capsules per bottle

Sep 15 2020;416:116998

How GLP-1 Medications Can Alleviate Back Pain While GLP-1 medications dont directly treat back pain, the secondary effects of weight loss can have profound benefits on spinal health

Injectable GLP-1 drugs like Ozempic were originally created to treat diabetes, but theyre now becoming famous for being a celebrity weight loss drug causing a shortage for patients who actually need it to treat their medical conditions